Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-402,639
Closed -$1.14M 224
2023
Q1
$1.14M Sell
402,639
-535,197
-57% -$1.4M 0.16% 121
2022
Q4
$2.55M Buy
937,836
+262,800
+39% +$766K 0.39% 61
2022
Q3
$1.91M Sell
675,036
-33,418
-5% -$94.8K 0.22% 96
2022
Q2
$1.78M Buy
708,454
+187,500
+36% +$535K 0.2% 111
2022
Q1
$1.68M Buy
520,954
+248,077
+91% +$693K 0.15% 111
2021
Q4
$764K Sell
272,877
-162,832
-37% -$467K 0.05% 193
2021
Q3
$1.2M Buy
435,709
+62,058
+17% +$196K 0.1% 169
2021
Q2
$1.28M Buy
373,651
+50,465
+16% +$164K 0.11% 212
2021
Q1
$886K Sell
323,186
-464,781
-59% -$1.31M 0.07% 221
2020
Q4
$2.41M Buy
787,967
+140,072
+22% +$378K 0.21% 136
2020
Q3
$1.46M Buy
647,895
+627,722
+3,112% +$1.57M 0.22% 132
2020
Q2
$53K Buy
+20,173
New +$47.6K 0.01% 242

Other funds holding ABEV

K2 Principal Fund's ABEV Position: Q2 2023 in Review

K2 Principal Fund sold out of Ambev (ABEV) in Q2 2023, closing a stake of 402,639 shares — an estimated $1.14M sold.

K2 Principal Fund first reported a position in ABEV in Q2 2020 and held it in 12 quarters. The position peaked at $2.55M in Q4 2022. 328 funds tracked by Wall St. Rank hold ABEV as of Q2 2023.

  • K2 Principal Fund reported no remaining Ambev position as of Q2 2023 after selling out during the quarter.
  • K2 Principal Fund sold 402,639 Ambev shares in Q2 2023, an estimated $1.14M.
  • K2 Principal Fund first reported a position in Ambev in Q2 2020 and held it in 12 quarters.
  • K2 Principal Fund's Ambev position peaked at $2.55M in Q4 2022.
  • 328 funds tracked by Wall St. Rank held Ambev as of Q2 2023.

Based on K2 Principal Fund's 13F filing for Q2 2023, filed 15 Aug 2023.